Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
Recruiting · NCT07227805 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Not applicable | 2026-09-21 | NCT07227805 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medtronic MiniMed, Inc. | 6 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cliniques Universitaires de Bruxelles - Hôpital Erasme | Brussels | Belgium | 3 |
| Sheba Medical Center | Ramat Gan | Israel | 43 |
| Sheba Medical Center, Edmond and Lily Safra Children's Hospital | Ramat Gan | Israel | 1 |
| Steno Diabetes Center Aarhus | Aarhus | Denmark | 2 |
| Steno Diabetes Center Copenhagen | Herlev | Denmark | 6 |
| Universitair Ziekenhuis Antwerpen | Antwerp | Belgium | 9 |
| University Medical Centre Ljubljana | Ljubljana | Slovenia | 9 |
| UZ Leuven | Leuven | Belgium | 82 |